drugset / Trial / NCT04768569
Noise-Induced Hearing Loss-Acute Exposure Treatment
Phase 2
Terminated
24 enrolled
Washington University School of Medicine
Gateway Biotechnology, Inc. · collabUnited States Department of Defense · collabUniversity of Texas · collab
RandomizedParallel-groupDouble-blindPrevention
Summary
The purpose of this study is to assess the safety and efficacy of zonisamide for the treatment of noise-induced hearing loss in adults.
Timeline
- Start
- 2021-10-04
- Primary completion
- 2023-09-29
- Completion
- 2023-09-29
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Zonisamide | Other / unclassified | 100 mg | Oral |